Gilbar Roy, Barnoy Sivia
School of Law, Netanya Academic College, Netanya, Israel.
The Stanley Steyer School of Health Professions, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Bioethics. 2018 Jul;32(6):378-387. doi: 10.1111/bioe.12448.
As in other areas of medical practice, relatives accompany patients to genetic consultations. However, unlike in other areas, the consultations may be relevant to the relatives' health because they may be at risk of developing the same genetic condition as the patient. The presence of relatives in genetic consultation may affect the decision-making process and it raises questions about the perception of patient autonomy and the way it is practiced in genetics. However, these issues have not been examined in previous empirical studies. This article aims to fill this gap by reporting findings from a qualitative study with clinicians working in the area of inherited breast cancer. The findings indicate that family presence has an impact on the patient's decisions to undergo genetic testing and preventative operations when she is diagnosed as a carrier. The findings further indicate that, unlike in other areas of medical practice, blood relatives who are present in consultations are perceived by clinicians as patients or potential patients, and this in turn increases their involvement in discussions in the consultation room. Finally, the findings indicate that in genetics, a relational approach to autonomy is applied. Decisions are made in a social context, where the relatives' views are heard and taken into account. The findings suggest that the conventional bioethical approach to autonomy, which perceives the decision-making unit as comprising a clinician and an individual patient, is challenged in genetics. The findings thus suggest that bioethicists, lawyers and policy-makers should consider whether this individualistic approach is still valid and applicable.
和医疗实践的其他领域一样,亲属会陪同患者进行基因咨询。然而,与其他领域不同的是,这些咨询可能与亲属的健康相关,因为他们可能有患与患者相同基因疾病的风险。亲属在基因咨询中的在场可能会影响决策过程,这也引发了关于患者自主性的认知以及在遗传学中如何实践患者自主性的问题。然而,这些问题在以往的实证研究中尚未得到探讨。本文旨在通过报告一项对从事遗传性乳腺癌领域工作的临床医生进行的定性研究结果来填补这一空白。研究结果表明,亲属在场会影响患者在被诊断为携带者时接受基因检测和预防性手术的决定。研究结果还进一步表明,与医疗实践的其他领域不同,临床医生将咨询中在场的血亲视为患者或潜在患者,这反过来又增加了他们在咨询室讨论中的参与度。最后,研究结果表明,在遗传学中采用了一种关于自主性的关系方法。决策是在一个社会背景下做出的,在这个背景下,亲属的意见会被听取并加以考虑。研究结果表明,传统的将决策单位视为由临床医生和个体患者组成的自主性生物伦理方法在遗传学中受到了挑战。因此,研究结果表明,生物伦理学家、律师和政策制定者应该考虑这种个人主义方法是否仍然有效和适用。